Physician profile
Eric Isaac Ray
NPI 1598965428
$3,474.37
in general payments reported to CMS, 2019-2025
24 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,491 · 2020: $697 · 2021: $519 · 2022: $206 · 2023: $185 · 2024: $114 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $933.16 | 2019-2025 | Xtampza |
| Boston Scientific Corporation | $907.57 | 2019-2025 | Intracept, General - Pain Management, Varithena Administration Pack |
| Vertiflex, INC. | $516.57 | 2019 | |
| Forte Bio-Pharma LLC | $302.13 | 2020-2021 | |
| Nevro Corp. | $171.47 | 2019-2024 | Senza |
| Epimed International, INC | $107.17 | 2020 | |
| Horizon Therapeutics Plc | $89.03 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.91 | 2019-2025 | Relistor |
| Pacira Pharmaceuticals Incorporated | $44.57 | 2023 | Exparel, Iovera |
| Arbor Pharmaceuticals, INC. | $40.20 | 2022 | |
| Abbott Laboratories | $35.87 | 2021 | |
| Azurity Pharmaceuticals, INC. | $32.44 | 2023-2024 | Horizant, Horizant |
| Pfizer INC. | $30.69 | 2019 | |
| Pacira Therapeutics, INC. | $28.92 | 2019 | |
| Painteq LLC | $23.17 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $22.98 | 2022 | |
| Avanos Medical | $17.71 | 2024 | Standard Rf Disposables |
| Relievant Medsystems, INC. | $17.05 | 2023 | Intracept |
| Almatica Pharma LLC | $16.42 | 2021 | |
| Sentynl Therapeutics, INC. | $16.13 | 2019 | |
| Ibsa Pharma INC. | $15.69 | 2020 | |
| Grt US Holding, INC. | $15.04 | 2022 | |
| Medtronic, INC. | $14.50 | 2021 | |
| Zyla Life Sciences, INC. | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.